Laparoscopic-assisted vs open surgery for synchronous colorectal cancer: a retrospective cohort study of short-term and long-term outcomes.
[BACKGROUND] The oncologic safety of laparoscopic-assisted surgery for synchronous colorectal cancer (SCRC), a distinct high-risk subgroup, remains under-investigated.
- p-value P = 0.003
- p-value P = 0.005
- 95% CI 0.35-1.06
APA
Liang J, Chen W, et al. (2026). Laparoscopic-assisted vs open surgery for synchronous colorectal cancer: a retrospective cohort study of short-term and long-term outcomes.. BMC gastroenterology, 26(1). https://doi.org/10.1186/s12876-025-04430-9
MLA
Liang J, et al.. "Laparoscopic-assisted vs open surgery for synchronous colorectal cancer: a retrospective cohort study of short-term and long-term outcomes.." BMC gastroenterology, vol. 26, no. 1, 2026.
PMID
41851844
Abstract
[BACKGROUND] The oncologic safety of laparoscopic-assisted surgery for synchronous colorectal cancer (SCRC), a distinct high-risk subgroup, remains under-investigated. This study aimed to compare the short-term and long-term outcomes of laparoscopic-assisted versus open surgery for SCRC.
[METHODS] A retrospective analysis of a cohort of 178 consecutive patients undergoing curative-intent surgery for SCRC between June 2007 and April 2019 was performed. To balance baseline covariates for the primary analysis, overlap weighting (OW) was applied to the cohort (133 laparoscopic, 45 open). A 1:1 propensity score matching (PSM) analysis was conducted as a sensitivity analysis. The primary outcomes were 5-year overall survival (OS) and 5-year disease-free survival (DFS).
[RESULTS] In the primary OW analysis, the laparoscopic group showed significantly less estimated blood loss (median, 100 mL vs. 200 mL; P = 0.003) and shorter time to first liquid diet (median, 4 vs. 5 days; P = 0.005) than the open surgery group. The two groups did not differ significantly in terms of 5-year OS (75.1% vs. 62.8%; P = 0.088) or 5-year DFS (65.69% vs. 59.3%; P = 0.110). Furthermore, in the multivariable Cox analysis, the laparoscopic approach was not an independent predictor of OS (adjusted HR, 0.61; 95% CI, 0.35-1.06) or DFS (adjusted HR, 0.70; 95% CI, 0.41-1.18). These findings were consistent in the PSM sensitivity analysis.
[CONCLUSIONS] In this study, laparoscopic-assisted surgery for SCRC offered improved short-term outcomes while maintaining long-term oncologic safety.
[METHODS] A retrospective analysis of a cohort of 178 consecutive patients undergoing curative-intent surgery for SCRC between June 2007 and April 2019 was performed. To balance baseline covariates for the primary analysis, overlap weighting (OW) was applied to the cohort (133 laparoscopic, 45 open). A 1:1 propensity score matching (PSM) analysis was conducted as a sensitivity analysis. The primary outcomes were 5-year overall survival (OS) and 5-year disease-free survival (DFS).
[RESULTS] In the primary OW analysis, the laparoscopic group showed significantly less estimated blood loss (median, 100 mL vs. 200 mL; P = 0.003) and shorter time to first liquid diet (median, 4 vs. 5 days; P = 0.005) than the open surgery group. The two groups did not differ significantly in terms of 5-year OS (75.1% vs. 62.8%; P = 0.088) or 5-year DFS (65.69% vs. 59.3%; P = 0.110). Furthermore, in the multivariable Cox analysis, the laparoscopic approach was not an independent predictor of OS (adjusted HR, 0.61; 95% CI, 0.35-1.06) or DFS (adjusted HR, 0.70; 95% CI, 0.41-1.18). These findings were consistent in the PSM sensitivity analysis.
[CONCLUSIONS] In this study, laparoscopic-assisted surgery for SCRC offered improved short-term outcomes while maintaining long-term oncologic safety.
MeSH Terms
Humans; Laparoscopy; Retrospective Studies; Male; Female; Colorectal Neoplasms; Middle Aged; Aged; Treatment Outcome; Propensity Score; Disease-Free Survival; Neoplasms, Multiple Primary; Colectomy; Blood Loss, Surgical
같은 제1저자의 인용 많은 논문 (5)
- Hierarchically engineered covalent organic framework nanoplatforms enable synergistic photothermal-photodynamic-chemotherapeutic breast cancer therapy.
- Imaging Immune Heterogeneity in Nasopharyngeal Carcinoma: A Multidimensional Radiomics Perspective.
- HS-Activable BiFeO Nanocatalysts for Ferroptosis-Driven Cancer Immunotherapy.
- Dual-center development and validation of an immunoinflammatory-based preoperative model for predicting postoperative cachexia in colorectal cancer.
- Loss of luminal lineage drives resistance to next-generation ERα antagonists in pretreated ER HER2 locally-advanced or metastatic breast cancer.